The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

Laboratory Developed Tests (LDTs) are critical for diagnosing rare diseases and addressing unmet clinical needs. They are developed, manufactured, ...

Researchers developed a wearable pad that detects inflammation and cancer biomarkers in menstrual blood using smartphone ...

The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more ...

David AuCoin, Ph.D., shares insights from his lab’s work developing prototype rapid diagnostic tests for infectious diseases ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

Other companies, such as Labcorp, Quest Diagnostics and others, have offered blood-based tests for a variety of biomarkers linked to the neurodegenerative disease, but as lab-developed tests ...

Diagnosis today typically requires invasive cystoscopy procedures. Pangea Laboratory is addressing this unmet need with Bladder CARE™, a groundbreaking non-invasive test developed to aid in the early ...